Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine

Travel Medicine and Infectious Disease

Volumn 13, Issue 3, 2015, Pages 241-250

  Jelinek, Tomas ^a   Cramer, Jakob P ^b   Dieckmann, Sebastian ^c   Hatz, Christoph ^d   Paulke Korinek, Maria ^e   Alberer, Martin ^f   Reisinger, Emil C ^g   Costantini, Marco ^h   Gniel, Dieter ⁱ   Bosse, Dietrich ⁱ   Lattanzi, Maria ^h  

^a Berlin Center for Travel and Tropical Medicine   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF ROSTOCK   (Germany)

^h NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

ⁱ Novartis Vaccines and Diagnostics Srl A GSK Company   (Germany)

Author keywords

Japanese encephalitis; Rabies; Vaccination

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; RABIES VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; MULTICENTER STUDY; NORMAL HUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RABIES; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; ADOLESCENT; ANIMAL; BLOOD; CHICK EMBRYO; CLINICAL TRIAL; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; PROCEDURES; RABIES VIRUS; TRAVEL; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHICK EMBRYO; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; JAPANESE ENCEPHALITIS VACCINES; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; RABIES VIRUS; TRAVEL; VACCINATION; YOUNG ADULT;

EID: 84945119147     PISSN: 14778939     EISSN: 18730442     Source Type: Journal    
DOI: 10.1016/j.tmaid.2015.05.008     Document Type: Article

References (21)

1. C. Malerczyk, L. Detora, and D. Gniel Imported human rabies cases in Europe, the United States, and Japan, 1990 to 2010 J Travel Med 18 2011 402 407
2. World Health Organization. International travel and health. Rabies. Available from: http://www.who.int/ith/vaccines/rabies/en/ [accessed March 2014].
3. P. Gautret, and P. Parola Rabies vaccination for international travelers Vaccine 30 2012 126 133
4. World Health Organization. International travel and health. Chapter 6. Vaccine-preventable diseases and vaccines 2013 update. Available from: http://www.who.int/ith/chapters/ith2012en-chap6.pdf?ua=1 [acessed March 2014].
5. M. Altmann, P. Parola, J. Delmont, P. Brouqui, and P. Gautret Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention J Travel Med 16 2009 107 111
6. S.B. Dolan, E.S. Jentes, M.J. Sotir, P. Han, J.D. Blanton, S.R. Rao, and et al. Pre-exposure rabies vaccination among US international travelers: findings from the Global TravEpiNet Consortium Vector Borne Zoonotic Dis 14 2014 160 167
7. M.R. Duffy, C. Reed, P.J. Edelson, S. Blumensaadt, K. Crocker, A. Griggs, and et al. A survey of US travelers to Asia to assess compliance with recommendations for the use of Japanese encephalitis vaccine J Travel Med 20 2013 165 170
8. P. Gautret, T. Tantawichien, V. Vu Hai, and W. Piyaphanee Determinants of pre-exposure rabies vaccination among foreign backpackers in Bangkok, Thailand Vaccine 29 2011 3931 3934
9. W. Piyaphanee, P. Shantavasinkul, W. Phumratanaprapin, P. Udomchaisakul, P. Wichianprasat, M. Benjavongkulchai, and et al. Rabies exposure risk among foreign backpackers in Southeast Asia Am J Trop Med Hyg 82 2010 1168 1171
10. K. Van Herck, J. Zuckerman, F. Castelli, P. Van Damme, E. Walker, R. Steffen, and et al. Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study J Travel Med 10 2003 75 78
11. Rabipur. Summary of product characteristics. Available from: http://www.eda.mohp.gov.eg/Download/Docs/Files/36-SPC.pdf. [accessed March 2014].
12. IXIARO. Summary of product characteristics. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000963/WC500037287.pdf. [accessed March 2014].
13. Kansas State University Rabies Laboratory. http://www.vet.k-state.edu/depts/dmp/service/rabies/.
14. S.A. Plotkin Correlates of protection induced by vaccination Clin Vaccine Immunol 17 2010 1055 1065
15. World Health Organisation Rabies vaccines. WHO position paper Wkly Epidemiol Rec (WER) 85 2010 309 320
16. S.M. Moore, and C.A. Hanlon Rabies-specific antibodies: measuring surrogates of protection against a fatal disease PLoS Negl Trop Dis 4 2010 e595
17. K. Pengsaa, K. Limkittikul, A. Sabchareon, C. Ariyasriwatana, P. Chanthavanich, P. Attanath, and et al. A three-year clinical study on immunogenicity, safety, and booster response of purified chick embryo cell rabies vaccine administered intramuscularly or intradermally to 12- to 18-month-old Thai children, concomitantly with Japanese encephalitis vaccine Pediatr Infect Dis J 28 2009 335 337
18. P. Khawplod, H. Wilde, M. Benjavongkulchai, C. Sriaroon, and P. Chomchey Immunogenicity study of abbreviated rabies preexposure vaccination schedules J Travel Med 14 2007 173 176
19. P. Shantavasinkul, T. Tantawichien, H. Wilde, A. Sawangvaree, A. Kumchat, N. Ruksaket, and et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study Clin Infect Dis 50 2010 56 60
20. O. Thraenhart, I. Marcus, and N. Scheiermann 3-1 scheme, a regimen of only two clinic visits with optimal antibody and interferon-induction progress in rabies control 1989 Wells Medical Kent, England 536 547
21. H. Wilde, P. Shantavasinkul, T. Hemachudha, V. Tepsumethanon, B. Lumlertacha, S. Wacharapluesadee, and et al. New knowledge and controversies in rabies J Infect Dis Antimicrob Agents 26 2009 63 74